Kiplinger Today

Stock Watch

5 Cheap Stocks Ready to Take Off

Tom Petruno

These market laggards have the potential to pay off big if investors' pessimism proves to be overblown.

Shoemaker with Legs

Wall Street is notorious for punishing companies that are willing to sacrifice earnings in the short run for potential long-term gains. That’s part of what’s been weighing lately on the shares of footwear firm Deckers Outdoor (DECK).

The maker of Ugg, Teva, Sanuk and other upscale shoe brands reported stellar earnings for the fourth quarter of 2013—up 46% from a year earlier, on a 19% rise in sales. But the Goleta, Cal., company also lowered profit expectations for the first half of 2014, citing among other things the cost of its continuing push to open more retail stores worldwide. Some analysts, including Corinna Freedman, of Wedbush Securities, think investors are being too shortsighted. Freedman expects sales in 2014 to rise 11%, to $1.7 billion, and earnings to climb 12%, to $4.65 per share.

Because it is free of debt, Deckers has a lot of financial flexibility. But it remains heavily dependent on its pricey Ugg footwear, which accounts for 83% of sales. The stock collapsed in 2012, when Ugg sales slipped 2% for the year and earnings slid 32%. But Ugg sales surged 19% in the fourth quarter of 2013 and 10% for the year. Deckers expects to use its growing base of retail stores to complement sales via other retailers and online. And it sees foreign markets—especially Asia—as hot growth areas. If the Ugg brand still has legs, so does Deckers stock.

Mattress Maker Firms Up

Tempur Sealy International (TPX) is trying to buy its way back to growth in the competitive mattress business. But so far, many investors have hit the snooze button.


The Lexington, Ky., company, then known as Tempur-Pedic International, rode the popularity of memory-foam mattresses to great success from 2009 to 2012, and its shares soared from less than $10 to a peak of $87. But vicious competition in the foam-mattress segment led to slowing sales and slumping profits in 2012. That drove Tempur to snap up rival Sealy Corp., a deal that CEO Mark Sarvary promised would create “tremendous value” for shareholders. The combined company’s sales hit $2.5 billion in 2013, making it the world’s biggest bedding maker. But earnings haven’t lived up to projections.

Sealy broadens the company’s line of mattresses. But Sealy’s lower-priced mattresses have lower profit margins than Tempur’s higher-end memory-foam bedding, at a time when Tempur needs more cash to whittle down a $1.8 billion debt load bloated by the merger. Still, KeyBanc Capital Markets says Tempur is experiencing an “exciting transformation” driven by new products, expansion overseas and cost-cutting. Analysts see profits surging 22% in 2015. That kind of growth should help Temper shares emerge from their slumber.

On the Watch List

Weight loss is a growth industry, which ought to mean great times for Weight Watchers International (WTW). But the firm’s fortunes have faded badly over the past two years. Revenue is expected to total $1.4 billion this year, down from a peak of $1.8 billion in 2012. Earnings are expected to come in at just $1.40 per share this year, compared with $4.23 in 2012. The stock has plunged from a high of $87 in May 2011 to $20.

Executives were slow to realize the increasing threat posed by free diet-plan mobile applications. Meanwhile, the company loaded up on debt to pay for stock buybacks. That double whammy leaves the New York City firm facing a very real threat of oblivion.

But Morningstar analyst R.J. Hottovy thinks new CEO Jim Chambers is taking the right steps to revive the franchise. That includes meshing the firm’s meal regimen and fee-generating dieter-support meetings with new online and mobile applications. The key, Hottovy says, is that, unlike so many other diet programs, Weight Watchers’ plans have been proven to work. If the 50-year-old firm can reinforce its message with consumers, employers and health plans in the U.S. and abroad, it could grab back market share.

Editor's Picks From Kiplinger


Permission to post your comment is assumed when you submit it. The name you provide will be used to identify your post, and NOT your e-mail address. We reserve the right to excerpt or edit any posted comments for clarity, appropriateness, civility, and relevance to the topic.
View our full privacy policy


Market Update